Editor Profile: Guest Editor of Special Issue on Targets and Anticancer Drug Research

by Liwu Fu
Published 2017-01-01

Small-molecule PROTACs: An emerging and promising approach for the development of targeted therapy drugs

by Sainan An, Liwu Fu
Published 2018-10-01

Mechanisms of resistance to EGFR tyrosine kinase inhibitors

by Lihua Huang, Liwu Fu
Published 2015-09-01

The role of ALDH2 in tumorigenesis and tumor progression: Targeting ALDH2 as a potential cancer treatment

by Hong Zhang, Liwu Fu
Published 2021-06-01

Tyrosine kinase inhibitors enhanced the efficacy of conventional chemotherapeutic agent in multidrug resistant cancer cells

by Shaocong Wu, Liwu Fu
Published 2018-02-01

Redox signaling-governed drug-tolerant persister cancer cell: a key spark of treatment failure

by Liwu Fu, Zhe-Sheng Chen
Published 2022-03-01

Therapeutic strategies for EGFR-mutated non-small cell lung cancer patients with osimertinib resistance

by Kai Fu, Fachao Xie, Fang Wang, Liwu Fu
Published 2022-12-01

The key roles of cancer stem cell-derived extracellular vesicles

by Chaoyue Su, Jianye Zhang, Yosef Yarden, Liwu Fu
Published 2021-03-01

KRAS mutation: from undruggable to druggable in cancer

by Lamei Huang, Zhixing Guo, Fang Wang, Liwu Fu
Published 2021-11-01

Targeting calcium signaling in cancer therapy

by Chaochu Cui, Robert Merritt, Liwu Fu, Zui Pan
Published 2017-01-01

CD39/CD73/A2AR pathway and cancer immunotherapy

by Chenglai Xia, Shuanghong Yin, Kenneth K. W. To, Liwu Fu
Published 2023-03-01

The strategies to cure cancer patients by eradicating cancer stem-like cells

by Yansui Mai, Jiyan Su, Chuan Yang, Chenglai Xia, Liwu Fu
Published 2023-10-01

The biomarkers of hyperprogressive disease in PD-1/PD-L1 blockage therapy

by Xueping Wang, Fang Wang, Mengjun Zhong, Yosef Yarden, Liwu Fu
Published 2020-05-01

Functions and mechanisms of circular RNAs in cancer radiotherapy and chemotherapy resistance

by Chaochu Cui, Jianbo Yang, Xiao Li, Dongling Liu, Liwu Fu, Xianwei Wang
Published 2020-03-01

Loss of FBXW7-mediated degradation of BRAF elicits resistance to BET inhibitors in adult T cell leukemia cells

by Chien-Hung Yeh, Marcia Bellon, Fang Wang, Hong Zhang, Liwu Fu, Christophe Nicot
Published 2020-09-01

Secalonic acid D induces cell apoptosis in both sensitive and ABCG2-overexpressing multidrug resistant cancer cells through upregulating c-Jun expression

by Hong Zhang, Liyan Huang, Liyang Tao, Jianye Zhang, Fang Wang, Xu Zhang, Liwu Fu
Published 2019-05-01

Author Correction: ABCG2-overexpressing H460/MX20 cell xenografts in athymic nude mice maintained original biochemical and cytological characteristics

by Wei Zhang, Zhen Chen, Likun Chen, Fang Wang, Furong Li, Xiaokun Wang, Liwu Fu
Published 2020-07-01

Reversal effect of FW-04-806, a macrolide dilactone compound, on multidrug resistance mediated by ABCB1 and ABCG2 in vitro and in vivo

by Zhiqiang Zhang, Chunling Ma, Peng Li, Min Wu, Shengnan Ye, Liwu Fu, Jianhua Xu
Published 2019-09-01

Human microbiomes in cancer development and therapy

by Chenglai Xia, Jiyan Su, Can Liu, Zhikai Mai, Shuanghong Yin, Chuansheng Yang, Liwu Fu
Published 2023-04-01

Clinical significance of FBXW7 loss of function in human cancers

by Jingyi Fan, Marcia Bellon, Mingyi Ju, Lin Zhao, Minjie Wei, Liwu Fu, Christophe Nicot
Published 2022-03-01